Christopher N. Berry

Author

Also Known As

Christopher N Berry, Christopher N. Berry

Publications

448

Citations

H-Index

Concepts

All Affiliations

Christopher N. Berry is an author at Sanofi (France) specializing in drug discovery, pharmacotherapy, and hematology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	285
2	Pharmacology	2	2	285
3	Drug Discovery	2	2	285
4	Natural Sciences	1	1	153
5	Biochemistry	1	1	153

Christopher N. Berry

Publications

431

Citations

H-Index

Page 1

	Year	Citations
Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin Christopher N. Berry, Christine Girardot, Catherine Lecoffreo, Thrombosis and Haemostasis Fibrin-bound Human ThrombinClot-incorporated ThrombinPharmacotherapyThrombosisMedicinal Chemistry	1994	153
SSR182289A, a selective and potent orally active thrombin inhibitor J.M. Altenburger, Gilbert Lassalle, Mostapha Matrougui, Bioorganic & Medicinal Chemistry ThrombosisBlood PlateletMedicineHematologyAnticoagulant	2004	132
Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time Christopher N. Berry, Denise Girard, Sylvette Lochot, British Journal of Pharmacology	1994	86
Inhibition by Argatroban, a Specific Thrombin Inhibitor, of Platelet Activation by Fibrin Clot-associated Thrombin Catherine Lunven, Christiane Gauffeny, Catherine Lecoffre, Thrombosis and Haemostasis	1996	38
SSR182289A, a Novel, Orally Active Thrombin Inhibitor: In Vitro Profile and ex Vivo Anticoagulant Activity Christopher N. Berry, Gilbert Lassalle, Catherine Lunven, Journal of Pharmacology and Experimental Therapeutics	2002	22

Page 1